NTLA vs CRSP
NTLA 与 CRSP 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | NTLAINTELLIA THERAPEUTICS, INC. | CRSPCRISPR THERAPEUTICS AG |
|---|---|---|
| 市值 | $1.50B | $4.79B |
| 市销率 | 22.2x | 1365.3x |
| 营收同比增长 | 16.9% | -90.6% |
| 净利同比增长 | 20.5% | -58.8% |
| 息税前利润率 | -651.7% | -18933.6% |
| 净资产收益率 | -66.5% | -33.3% |
| 投入资本回报率 | — | -32.6% |
| 一年总回报 | -6.2% | -11.7% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:NTLA vs CRSP
| 指标 | NTLA | CRSP |
|---|---|---|
| 期末价值 | $8.5K | $35.2K |
| 总回报 | -14.6% | +251.8% |
| 年化收益 (CAGR) | -1.6% | +13.7% |
| 波动率 | 78.7% | 64.1% |
| 夏普比率 | 0.32 | 0.46 |
| 索提诺比率 | 0.48 | 0.71 |
| 最大回撤 | -96.5% | -85.1% |
基于 2459 个共同交易日,2016-10-19 → 2026-08-03 · 无风险利率 3.91%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)